Welcome to our dedicated page for Olaplex Holdings SEC filings (Ticker: OLPX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Olaplex Holdings, Inc. filings document the formal disclosures of a Nasdaq-listed beauty company with common stock registered under the symbol OLPX. Recent Form 8-K reports cover results of operations and financial condition, including sales performance across professional, specialty retail, and direct-to-consumer channels and U.S. and international markets.
The filing record also documents material definitive agreements, capital-structure disclosures, shareholder voting matters, governance changes, and compensatory arrangements. Company-specific disclosures include the completed acquisition of Purvala Bioscience by an Olaplex subsidiary, board composition updates, and other material-event reporting tied to the company’s hair-care innovation and public-company obligations.
Olaplex (NASDAQ: OLPX) filed a routine Form 4 on June 29, 2025. The filing states that former director Paula Zusi ceased serving on the board effective June 10, 2025 and is therefore no longer subject to Section 16 reporting requirements. No purchases, sales, or other equity transactions were disclosed, and the tables for both non-derivative and derivative securities list no entries. The document is filed voluntarily to formally register Ms. Zusi’s change in reporting status.
Because the Form 4 reports no share transactions or monetary amounts, it represents an administrative update rather than a market-moving event.